Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks

  1. Murray, M.
  2. Antela, A.
  3. Mills, A.
  4. Huang, J.
  5. Jäger, H.
  6. Bernal, E.
  7. Lombaard, J.
  8. Katner, H.
  9. Walmsley, S.
  10. Khuong-Josses, M.-A.
  11. Hudson, K.
  12. Dorey, D.
  13. Griffith, S.
  14. Spreen, W.
  15. Vanveggel, S.
  16. Shaefer, M.
  17. Margolis, D.
  18. Chounta, V.
Journal:
AIDS and Behavior

ISSN: 1573-3254 1090-7165

Year of publication: 2020

Volume: 24

Issue: 12

Pages: 3533-3544

Type: Article

DOI: 10.1007/S10461-020-02929-8 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals